Positive Results from Burn Validation Study
The DeepView system demonstrated exceptional performance in predicting burn healing potential, outperforming clinicians in sensitivity, Dice Score, and specificity. Sensitivity reached 86.6% compared to 40.8% by physicians.
Record Research and Development Revenue
R&D revenue reached $29.6 million in 2024, marking a 63.5% increase from the previous year, driven by expanded work on the BARDA PBS contract.
Successful Deployment in Australia and the UK
Spectral AI successfully deployed three DeepView systems in Australia and gathered positive feedback from UK specialists, expanding the company's international presence.
Formation and Spin-off of Spectral IP
Spectral AI formed Spectral IP to monetize IP assets, with an anticipated spin-off into an independent publicly traded company.
Improved Financial Position
The company improved its financial position with cash and cash equivalents exceeding $14 million following long-term debt financing.